By Mukhtar Alam (Pakistan News & Features Services) The researchers at Karachi’s Dow University of Health Sciences (DUHS), on April 13, claimed having achieved a significant breakthrough in the fight against COVID-19. They, according to a DUHS press release, have succeeded in preparing intravenous immunoglobulin (IVIG) with plasma obtained from cured patients of coronavirus. “Through the IVIG the coronavirus patients can be treated.” The researchers, led by Dr Shaukat Ali, Principal, Dow College of Biotechnology, were of the view that their method was considerably different from plasma therapy, which is allowed only in emergencies due to its side effects. “Treating a coronavirus patient with IVIG is safe and highly effective, with small risk.” They further remarked that the treatment by hyper immunoglobulin (H-IVIG) is already approved by the US Federal agency, Food and Drug Administration (FDA), for normal conditions. The press release said that the research team ...
Stay updated with Shehri TV for the latest Pakistan news, current affairs, entertainment, social issues, business, technology, sports, and trending videos from across the country. Pakistan News, Current Affairs, Karachi News, Business News, Technology News, Entertainment News, Sports News, Social Issues, Public Interest Stories, Latest Updates